Anavex Life Sciences Corp (AVXL)

[jimmy667]

The real money is a few years away. The 30 to 300 run. It is more likely that those individuals and institutions who pay up for this later will hold for longer. But if one where to hold from here on of course will do the best but many will think 30 or 50 is great and be satisfied. If this works the market just for ALZ will be geometrically larger than it is especially if effective at an early stage. The reason is simple but overlooked. Doctors do not actively search for signs
of ALZ early because they do not have a treatment for it. If we can find a effective treatment early diagnosic protocols will be developed greatly expanding the market. Same true for some of the other indications as well. MC of commercial developed AVXL will dwarf current ISRG mcap and the market for the drugs shared shared with partners of course will be geometrically larger than GILDs antiViral markets.